$PME (+0,02 %) has released its financial results and is delivering impressive numbers:
Revenue rose by 22.9 percent to 261.7 million Australian dollars, and by as much as 28.4 percent on a currency-adjusted basis. Adjusted net income climbed by 24.1 percent to 144.7 million Australian dollars.
Reported net income soared by 130.3 percent to 265.3 million Australian dollars—driven by a valuation gain from its stake in the AI company 4DMedical, which alone contributed approximately 172 million Australian dollars to the result.
The operating margin rose to 74.9 percent, an increase of 90 basis points. Cash and cash equivalents, including financial assets, grew by just under 20 percent to 252.3 million Australian dollars, with a cash conversion rate of 91 percent. Shareholders will receive a 25.5 percent higher dividend of 69 cents per share, which is fully tax-deductible against Australian corporate income tax.
